Homogeneous reactant-labeled fluorescent immunoassay for therapeutic drugs exemplified by gentamicin determination in human serum.
Author:
Burd J F,Wong R C,Feeney J E,Carrico R J,Boguslaski R C
Abstract
Abstract
We applied a homogeneous reactant-labeled fluorescent immunoassay to the measurement of therapeutic drug concentrations in human serum, exemplified here by gentamicin. A derivative of umbelliferyl-beta-galactoside was coupled covalently to the drug and this conjugate was found to be nonfluorescent under assay conditions. The drug/dye conjugate was a substrate for bacterial beta-galactosidase and yielded a fluorescent product. When the drug/dye conjugate was bound to anti-gentamicin antibody it was inactive as an enzymatic substrate. This inactivation was relieved by the presence of gentamicin in competitive binding reactions. Hence, the rate of production of fluorescence was proportional to the gentamicin concentration. The fluorescent assay yielded values which compared favorably to a radioimmunoassay for gentamicin in clinical serum samples (r=0.94, standard error of estimate=0.66 mg/liter). The fluorescent assay requires only 1 microliter of serum and offers several advantages over existing techniques: sensitivity, specificity, simplicity, and the obviation of radioisotopes.
Publisher
Oxford University Press (OUP)
Subject
Biochemistry (medical),Clinical Biochemistry
Cited by
107 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immunoassay;Kirk-Othmer Encyclopedia of Chemical Technology;2016-06-15
2. Amplification Techniques for Optical Detection;Biomedical Photonics Handbook, Second Edition;2014-07-30
3. Immunoassays and Immunochemistry;Henry's Clinical Diagnosis and Management by Laboratory Methods;2011
4. Microbial Biosynthesis and Applications of Gentamicin: A Critical Appraisal;Critical Reviews in Biotechnology;2008-01
5. Toxicology: Then and now;Clinical Biochemistry;2006-05